| |
| |
|
| Insider
Information: |
Haumann Brett K |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
242,499 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,211,591 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
242,499 |
|
|
| Total
Value |
$2,211,591 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 1.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Theravance Biopharma, Inc. |
TBPH |
Chief Medical Officer |
2021-02-20 |
242,499 |
2015-02-05 |
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
Chief Medical Officer |
• – – |
2021-02-20 |
4 |
D |
$18.79 |
$670,277 |
D/D |
(35,672) |
242,499 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Medical Officer |
• – – |
2020-11-20 |
4 |
D |
$17.21 |
$79,837 |
D/D |
(4,639) |
278,171 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$459,299 |
D/D |
(13,313) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$215,625 |
D/D |
(6,250) |
0 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Medical Officer |
• – – |
2020-08-21 |
4 |
S |
$18.29 |
$457,240 |
D/D |
(25,000) |
282,810 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Medical Officer |
• – – |
2020-08-20 |
4 |
D |
$18.22 |
$84,650 |
D/D |
(4,646) |
307,810 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
13,313 |
19,563 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2020-05-20 |
4 |
D |
$26.67 |
$112,334 |
D/D |
(4,212) |
312,456 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$870,447 |
D/D |
(33,608) |
316,668 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
350,276 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-11-20 |
4 |
D |
$17.60 |
$47,379 |
D/D |
(2,692) |
231,276 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-08-20 |
4 |
D |
$21.51 |
$58,292 |
D/D |
(2,710) |
233,968 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-05-20 |
4 |
D |
$19.84 |
$53,667 |
D/D |
(2,705) |
236,678 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-02-20 |
4 |
D |
$27.00 |
$210,006 |
D/D |
(7,778) |
239,383 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
247,161 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2018-11-20 |
4 |
D |
$24.79 |
$182,653 |
D/D |
(7,368) |
134,911 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2018-08-20 |
4 |
D |
$26.95 |
$180,107 |
D/D |
(6,683) |
142,279 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2018-05-20 |
4 |
D |
$24.31 |
$656,151 |
D/D |
(26,991) |
148,962 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
175,953 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2018-02-20 |
4 |
D |
$29.09 |
$241,243 |
D/D |
(8,293) |
142,203 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
150,496 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2017-11-20 |
4 |
D |
$28.58 |
$224,239 |
D/D |
(7,846) |
141,496 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2017-08-20 |
4 |
D |
$27.40 |
$193,554 |
D/D |
(7,064) |
149,342 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2017-05-20 |
4 |
D |
$36.83 |
$260,204 |
D/D |
(7,065) |
156,406 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP Clin Dev & Chief Med Ofc |
• – – |
2017-03-07 |
4 |
S |
$30.80 |
$13,059 |
D/D |
(424) |
163,471 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
